Defibrillators Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

Global Defibrillator Market is foreseen to be priced at around US$ 20.84 Billion by 2030. In modern days, the defibrillator is a life-saving medical device designed to restore a standard coronary heart rhythm in people experiencing cardiac arrest or arrhythmia. It supplies an electric shock to the heart, known as defibrillation, that can stop chaotic electrical activity and permit the heart to resume its regular beating pattern. Automated External Defibrillators (AEDs) are typically found in public places. They are user-friendly, presenting voice prompts and visual commands to guide bystanders by providing shock. Speed is vital in cardiac emergencies, and defibrillators play a pivotal role in growing survival rates by providing on-the-spot treatment before professional medical assistance arrives. They are essential tools in the chain of survival for sudden cardiac arrest patients.

Global Defibrillator Market is anticipated to develop at a CAGR of 7.20% between 2024 and 2030

The World Heart Federation reports that cardiovascular diseases, which include cardiac arrest, claim 17.9 million lives annually, ranking as the primary reason for dying worldwide. As the population ages, the need for defibrillators in hospitals and public spaces increases. This is because the risk of cardiovascular problems increases with age. Additionally, advancements in defibrillator technology and increased awareness among the public have led to better survival rates following cardiac arrest. These factors have contributed to a growing market for defibrillators.

Defibrillators have undergone significant technological advancements, leading to smaller, lighter, and more user-friendly designs. Public Access Defibrillators are increasingly available in public spaces, and home defibrillators are now more affordable and accessible, providing peace of mind to those at high risk. These advancements are improving accessibility and readiness in various settings.

North America is the leading region in the defibrillator market due to high healthcare spending, an aging population, and awareness of cardiovascular diseases. The market has immense potential, and using drones with defibrillators can save lives in remote or congested areas where time is of the essence. The future of defibrillators looks promising with advancements in wearable technology, miniaturization, and improved monitoring capabilities that can provide immediate intervention for at-risk individuals. Additionally, ongoing research on implantable defibrillators aims to introduce advanced features and extend their lifespan, potentially revolutionizing cardiac care for high-risk patients. Hence, the worth of the Global Defibrillator Market was US$ 12.81 Billion in 2023.

Implantable defibrillators assert dominance in the worldwide market due to their effectiveness in preventing sudden cardiac death

By product, the global defibrillator market is fragmented into Implantable Defibrillators and External Defibrillators. Implantable defibrillators are expected to lead the market. They continuously monitor heart rhythm and provide a life-saving shock when irregularities are detected, offering instantaneous intervention. The developing incidence of cardiovascular illnesses and technological advancements propel the demand for implantable defibrillators. Also, ongoing studies are special in improving features and extending device lifespans, making them reliable for high-risk patients. With their capacity to provide continuous safety and improved patient results, implantable defibrillators are pivotal in the evolving landscape of international cardiac care.

Hospitals head the global defibrillator market

By end-user, the global defibrillator market is categorized into Hospital, Pre-hospital, Public Access Market, Alternate Care Market, and Home Healthcare. The hospital section is anticipated to dominate the defibrillator market. Hospitals need defibrillators for treating cardiac emergencies. They invest in modern defibrillator technology to treat sudden cardiac arrest cases effectively. Their significant role in healthcare delivery positions hospitals as leaders in driving innovation in the defibrillator market.

The United States commands a significant share of the global defibrillator market

By countries, the global defibrillator market is divided into North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), Latin America (Brazil, Mexico, Argentina), Middle East & Africa (South Africa, Saudi Arabia, UAE). According to the American Heart Association, in the United States, 356,000 out-of-hospital cardiac arrests arise annually, propelling the demand for defibrillators. High recognition of cardiovascular diseases, sturdy healthcare infrastructure, and a growing old population contribute to this need. Rigorous studies, favorable reimbursement regulations, and public access to defibrillator applications stimulate market growth. Stringent policies and a culture of prompt emergency response boost the U.S.'s impact. With a dedication to advancing cardiac care, the nation remains a massive force in the global defibrillator market.

Key Players

Medtronic Plc, Boston Scientific Corporation, Philips Healthcare, Nihon Kohden Corporation, Asahi Kasei Corporation, Stryker Corporation, Abbott, and LivaNova PLC are the notable companies in the global defibrillator market.

In August 2022 - Medtronic's new EV ICD system achieved trial endpoints. It is a minimally invasive device that reduces risks by placing its lead outside the heart and veins beneath the sternum.

The report titled “Global Defibrillator Market By Product (Implantable Defibrillators, and External Defibrillators), End-Users (Hospital, Pre-hospital, Public Access Market, Alternate Care Market, and Home Healthcare), Countries (North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia Pacific (China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand), Latin America (Brazil, Mexico, Argentina), Middle East & Africa (Saudi Arabia, UAE, South Africa)), Company Analysis (Medtronic Plc, Boston Scientific Corporation, Philips Healthcare, Nihon Kohden Corporation, Asahi Kasei Corporation, Stryker Corporation, Abbott, and LivaNova PLC)” provides a complete study of Global Defibrillator Industry.

Product - Global Defibrillator Market breakup in 2 viewpoints:

1. Implantable Defibrillators
2. External Defibrillators

End-Users - Global Defibrillator Market breakup in 5 viewpoints:

1. Hospital
2. Pre-hospital
3. Public Access Market
4. Alternate Care Market
5. Home Healthcare

Countries - Global Defibrillator Market breakup in 5 viewpoints:

1. North America
1.1 United States
1.2 Canada

2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey

3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand

4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina

5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa

All the Key players have been covered from 3 Viewpoints:

• Overview
• Recent Developments
• Revenue Analysis

Company Analysis:

1. Medtronic Plc
2. Boston Scientific Corporation
3. Philips Healthcare
4. Nihon Kohden Corporation
5. Asahi Kasei Corporation
6. Stryker Corporation
7. Abbott
8. LivaNova PLC